Showing 919 results

Filters Content type: News, Editors' picks Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

Weight gain & lipodystrophy

Weight gain, raised blood pressure risk seen for HIV patients switching to dolutegravir

Editor's pick
Medical Xpress
22 March 2023
PrEP

CROI 2023: Bone density profiles for long-acting cabotegravir vs TDF/FTC oral PrEP in young people

Editor's pick
i-Base
9 March 2023
Cardiovascular disease

HIV drug may be linked to increased risk of hypertension

Editor's pick
Medical Xpress
22 February 2023
Side effects

Researchers identify how HIV/hepatitis drug harms the kidneys

Editor's pick
Medical Xpress
18 January 2023
PrEP science

Daily PrEP is safe for the kidneys, although on-demand PrEP has slightly less impact

News
30 December 2022
Weight gain & lipodystrophy

Obesity Risk Higher With DTG Than Other Regimens in 3 Big African Trials

Editor's pick
NATAP
1 November 2022
Side effects

CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention

News
27 October 2022
Side effects

Go Slow Before Switching HIV Meds Due to Metabolic Effects

Editor's pick
Infectious Disease Special Edition
14 September 2022
Bone & joint problems

Vitamin D and calcium supplements suggested to avert bone disease in people taking tenofovir-based ART and PrEP

News
24 August 2022
Weight gain & lipodystrophy

Weight gain on treatment: more evidence that TAF plus dolutegravir leads to greater gains

News
29 July 2022
HIV treatment

Mozambique: Half a Million HIV-Positive People Abandon Anti-Retroviral Treatment

Editor's pick
AllAfrica
29 July 2022
Changing treatment

‘The Devil You Know’: Many People Over 50 Are Taking Outdated ART, Despite Side Effects

Editor's pick
TheBodyPro
27 April 2022
PEP

Study shows Biktarvy for PEP has fewer side effects and better completion rates

News
16 March 2022
Bone & joint problems

Better adherence to PrEP is associated with more bone loss

News
9 March 2022
PrEP science

Kidney Toxicity Rare With Daily or On-Demand (As-Needed) PrEP

Editor's pick
NATAP
31 October 2021
Side effects

Large international study finds 40% higher risk of serious cardiovascular problems in people taking abacavir since 2012

News
28 October 2021
Cardiovascular disease

Large US study confirms that people switching from TDF to TAF experience rising blood fat levels

News
15 October 2021
Weight gain & lipodystrophy

Older version of tenofovir used as PrEP linked to weight loss

News
5 October 2021
PrEP science

Most switches to Descovy PrEP are probably unnecessary and some may be harmful

News
1 October 2021
Kidney problems

People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP

News
21 September 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
Pharmaceutical industry

Negative innovation: when patents are bad for patients

Editor's pick
Nature
12 August 2021
New & experimental HIV treatments

HIV: Could Another Two-Drug Regimen Be on the Horizon?

Editor's pick
Medscape (requires free registration)
21 July 2021
Neurological & cognitive problems

New predictors for peripheral neuropathy found in study of people living with HIV

News
6 July 2021